Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of the Efficacy of Biobran (Rice Bran Arabinoxylan) in Supporting Breast Cancer Chemotherapy
Sponsor: China Medical University Hospital
Summary
This study aims to evaluate the potential supportive effects of rice bran arabinoxylan compound (Biobran) in patients with breast cancer receiving paclitaxel and doxorubicin chemotherapy. The study will assess chemotherapy-related side effects, quality of life, tumor size, tumor antigens, and routine blood test parameters over 24 weeks of treatment.
Key Details
Gender
FEMALE
Age Range
20 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
96
Start Date
2025-04-07
Completion Date
2026-08-31
Last Updated
2026-03-31
Healthy Volunteers
No
Interventions
Biobran supplementation
3 g Biobran per day for 24 weeks
Locations (2)
China Medical University Hospital
Taichung, Taiwan
China Medical University
Taichung, Taiwan